CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis
Oncology Research · 2026 · 34 (6) · 1-10
DOI: 10.32604/or.2026.073934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Wenjian Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Cisplatin, Cyclin-Dependent Kinase 4, Carcinoma, Renal Cell, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Zeng, W., Li, X., Cai, H., Zhou, Q., Sun, S., Li, P., Li, S., & Chen, Z. (2026). CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.073934
Vancouver
Zeng W, Li X, Cai H, Zhou Q, Sun S, Li P, et al. CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.073934
BibTeX
@article{Zeng2026,
author = {Zeng, Wenjian and Li, Xianglong and Cai, Hao and Zhou, Qingyu and Sun, Shuangshuang and Li, Pingping and Li, Sunlong and Chen, Zhi},
title = {CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {6},
pages = {1--10},
doi = {10.32604/or.2026.073934}
}
EUVIMED